Advertisement
UK markets closed
  • FTSE 100

    8,164.12
    -15.56 (-0.19%)
     
  • FTSE 250

    20,286.03
    -45.77 (-0.23%)
     
  • AIM

    764.38
    -0.09 (-0.01%)
     
  • GBP/EUR

    1.1796
    -0.0009 (-0.07%)
     
  • GBP/USD

    1.2646
    +0.0005 (+0.04%)
     
  • Bitcoin GBP

    48,701.73
    +558.45 (+1.16%)
     
  • CMC Crypto 200

    1,281.44
    -2.39 (-0.19%)
     
  • S&P 500

    5,460.48
    -22.39 (-0.41%)
     
  • DOW

    39,118.86
    -45.24 (-0.12%)
     
  • CRUDE OIL

    81.46
    -0.28 (-0.34%)
     
  • GOLD FUTURES

    2,336.90
    +0.30 (+0.01%)
     
  • NIKKEI 225

    39,583.08
    +241.58 (+0.61%)
     
  • HANG SENG

    17,718.61
    +2.11 (+0.01%)
     
  • DAX

    18,235.45
    +24.85 (+0.14%)
     
  • CAC 40

    7,479.40
    -51.32 (-0.68%)
     

RxSight, Inc. (RXST) Just Overtook the 20-Day Moving Average

RxSight, Inc. (RXST) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, RXST crossed above the 20-day moving average, suggesting a short-term bullish trend.

The 20-day simple moving average is a popular investing tool. Traders like this SMA because it offers a look back at a stock's price over a shorter period and helps smooth out price fluctuations. The 20-day can also show more trend reversal signals than longer-term moving averages.

Similar to other SMAs, if a stock's price moves above the 20-day, the trend is considered positive, while price falling below the moving average can signal a downward trend.

Over the past four weeks, RXST has gained 29.3%. The company is currently ranked a Zacks Rank #3 (Hold), another strong indication the stock could move even higher.

ADVERTISEMENT

Once investors consider RXST's positive earnings estimate revisions, the bullish case only solidifies. No earnings estimate has been lowered in the past two months, compared to 3 raised estimates, for the current fiscal year, and the consensus estimate has increased as well.

Given this move in earnings estimate revisions and the positive technical factor, investors may want to keep their eye on RXST for more gains in the near future.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

RxSight, Inc. (RXST) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research